FDA — authorised 17 April 1998
- Application: NDA020819
- Marketing authorisation holder: ABBVIE
- Status: supplemented
🇺🇸 Zemplar in United States
FDA authorised Zemplar on 17 April 1998
Marketing authorisations
FDA — authorised 26 May 2005
- Application: NDA021606
- Marketing authorisation holder: ABBVIE
- Status: supplemented
FDA
- Status: approved
Other Nephrology approved in United States
Frequently asked questions
Is Zemplar approved in United States?
Yes. FDA authorised it on 17 April 1998; FDA authorised it on 26 May 2005; FDA has authorised it.
Who is the marketing authorisation holder for Zemplar in United States?
ABBVIE holds the US marketing authorisation.